September #39 : The Heart of the Matter - by Lark Lands, PhD

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Talking 'Bout Their Generation

Youth to Youth

Bargaining Power

Growing Up in Public

Liver Worst

Family Tree

Blood Lines

S.O.S.

To the Editor

And on the 7th Day...

In the Sack

Vertex Vortex

Pump and Grind

Baby Gap

You Can’t Touch This

Aloe Can You Go?

Death by Bureaucracy

Bubonic Tonic

Say What

Say What

All Apologies

Plenty of Nothing

Rough Cuts

POZ Picks

Spin and Needles

No Miss Manners

HIV Confidential

Making a Scene

Obits

Presidential Nemesis

Are the Kids Alright?

Kid Gloves

Prime-Time Lives

Don’t Make Me Over

Confessions of a Jerk

Life Lessons

Quality Time

Valuable Kitchen Tool

Better Safe Than Sushi

The Heart of the Matter

To C or Not to C

The Circle Game

Youth on Drugs

Uncertain-teens

Making the Grade

Finger on the Pulses

Fountain of Youth

Where to find it

Reality Check

Leftovers



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

September 1998

The Heart of the Matter

by Lark Lands, PhD

First reports linking protease drugs and heart disease

Add heart disease right at the top of the growing list of protease inhibitor–induced troubles suffered by PWAs around the country. Keith Henry, MD, of Regions Hospital in St. Paul, Minnesota, and his colleagues report that one-third of their 124 patients on protease combo therapies have developed high triglycerides (a type of blood fat), a worrisome possible precursor to cardiovascular complications. And two of their patients already have angina, the chest pain that is often a warning sign of more severe heart problems to come. In fact, both of these patients were found to have seriously clogged arteries.

Other HIV specialists have reported heart attacks in patients on protease combos, leading to considerable concern that this is the start of a dangerous trend. In an off-the-record meeting, one clinician said, “I’m very worried that we’re treating people for HIV now with meds that will mean we’ll be treating them for heart disease down the line.” Encouraging your doctor to monitor your triglycerides and total cholesterol is important. If elevated (see What This Means in last month’s POZ), many physicians recommend diet and exercise programs, along with cholesterol-lowering drugs. In addition, nutritionists suggest taking the antioxidants known to provide protection against arterial damage—especially vitamin E in doses of 800 to 1,200 IU daily.




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    acousticmat
    Tucson
    Arizona


    oceanblue65
    louisiana
    Louisiana


    youngbloodlatino
    Columbia
    Maryland


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.